Novel Inhibitors Of Mycobacterium Tuberculosis Complex Cytochrome P450 Cyp121

Full-text?

The full document isn't yet available to us from the patent office.

Abstract

The present invention relates to the identification of the cyclodipeptide cyclo(L-Tyr-L-Tyr) as substrate of CYP121 from Mycobacterium tuberculosis, to the crystal structures of CYP121 complexed either with cyclo(L-Tyr-L-Tyr) or with other cyclodipeptides, to the use of these structures in rational drug design methods to generate cyclodipeptide-based molecules that could inhibit CYP121 activity, and to the design of new anti- Mycobacterium tuberculosis agents based on the DKP scaffold.


Claims

Information currently unavailable.

Sign in to the Lens

Feedback